Ketoconazole is an antifungal medication which is used primarily to treat fungal infections. Ketoconazole is sold commercially as a tablet for oral administration (although this use has been discontinued in a number of countries), and in a variety of formulations for topical administration, such as creams (used to treat tinea; cutaneous candidiasis, including candidal paronychia; and pityriasis versicolor) and shampoos (used primarily to treat dandruff – seborrhoeic dermatitis of the scalp).
LPI (LP Information)' newest research report, the “Ketoconazole Industry Forecast” looks at past sales and reviews total world Ketoconazole sales in 2022, providing a comprehensive analysis by region and market sector of projected Ketoconazole sales for 2023 through 2029. With Ketoconazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Ketoconazole industry.
This Insight Report provides a comprehensive analysis of the global Ketoconazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Ketoconazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Ketoconazole market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Ketoconazole and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Ketoconazole.
The global Ketoconazole market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Ketoconazole is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Ketoconazole is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Ketoconazole is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Ketoconazole players cover Mylan, Almirall, j&j, Taro Pharmaceutical, Teva Pharmaceutical, SANDOZ and Strides Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Ketoconazole market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Ketoconazole Oral
Ketoconazole Topical
Ketoconazole Shampoo
Segmentation by application
Antifungal
Non-fungal conditions
Hair Loss
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Mylan
Almirall
j&j
Taro Pharmaceutical
Teva Pharmaceutical
SANDOZ
Strides Pharma

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Ketoconazole Market Size 2018-2029 2.1.2 Ketoconazole Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Ketoconazole Segment by Type 2.2.1 Ketoconazole Oral 2.2.2 Ketoconazole Topical 2.2.3 Ketoconazole Shampoo 2.3 Ketoconazole Market Size by Type 2.3.1 Ketoconazole Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Ketoconazole Market Size Market Share by Type (2018-2023) 2.4 Ketoconazole Segment by Application 2.4.1 Antifungal 2.4.2 Non-fungal conditions 2.4.3 Hair Loss 2.5 Ketoconazole Market Size by Application 2.5.1 Ketoconazole Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Ketoconazole Market Size Market Share by Application (2018-2023) 3 Ketoconazole Market Size by Player 3.1 Ketoconazole Market Size Market Share by Players 3.1.1 Global Ketoconazole Revenue by Players (2018-2023) 3.1.2 Global Ketoconazole Revenue Market Share by Players (2018-2023) 3.2 Global Ketoconazole Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Ketoconazole by Regions 4.1 Ketoconazole Market Size by Regions (2018-2023) 4.2 Americas Ketoconazole Market Size Growth (2018-2023) 4.3 APAC Ketoconazole Market Size Growth (2018-2023) 4.4 Europe Ketoconazole Market Size Growth (2018-2023) 4.5 Middle East & Africa Ketoconazole Market Size Growth (2018-2023) 5 Americas 5.1 Americas Ketoconazole Market Size by Country (2018-2023) 5.2 Americas Ketoconazole Market Size by Type (2018-2023) 5.3 Americas Ketoconazole Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Ketoconazole Market Size by Region (2018-2023) 6.2 APAC Ketoconazole Market Size by Type (2018-2023) 6.3 APAC Ketoconazole Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Ketoconazole by Country (2018-2023) 7.2 Europe Ketoconazole Market Size by Type (2018-2023) 7.3 Europe Ketoconazole Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Ketoconazole by Region (2018-2023) 8.2 Middle East & Africa Ketoconazole Market Size by Type (2018-2023) 8.3 Middle East & Africa Ketoconazole Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Ketoconazole Market Forecast 10.1 Global Ketoconazole Forecast by Regions (2024-2029) 10.1.1 Global Ketoconazole Forecast by Regions (2024-2029) 10.1.2 Americas Ketoconazole Forecast 10.1.3 APAC Ketoconazole Forecast 10.1.4 Europe Ketoconazole Forecast 10.1.5 Middle East & Africa Ketoconazole Forecast 10.2 Americas Ketoconazole Forecast by Country (2024-2029) 10.2.1 United States Ketoconazole Market Forecast 10.2.2 Canada Ketoconazole Market Forecast 10.2.3 Mexico Ketoconazole Market Forecast 10.2.4 Brazil Ketoconazole Market Forecast 10.3 APAC Ketoconazole Forecast by Region (2024-2029) 10.3.1 China Ketoconazole Market Forecast 10.3.2 Japan Ketoconazole Market Forecast 10.3.3 Korea Ketoconazole Market Forecast 10.3.4 Southeast Asia Ketoconazole Market Forecast 10.3.5 India Ketoconazole Market Forecast 10.3.6 Australia Ketoconazole Market Forecast 10.4 Europe Ketoconazole Forecast by Country (2024-2029) 10.4.1 Germany Ketoconazole Market Forecast 10.4.2 France Ketoconazole Market Forecast 10.4.3 UK Ketoconazole Market Forecast 10.4.4 Italy Ketoconazole Market Forecast 10.4.5 Russia Ketoconazole Market Forecast 10.5 Middle East & Africa Ketoconazole Forecast by Region (2024-2029) 10.5.1 Egypt Ketoconazole Market Forecast 10.5.2 South Africa Ketoconazole Market Forecast 10.5.3 Israel Ketoconazole Market Forecast 10.5.4 Turkey Ketoconazole Market Forecast 10.5.5 GCC Countries Ketoconazole Market Forecast 10.6 Global Ketoconazole Forecast by Type (2024-2029) 10.7 Global Ketoconazole Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Mylan 11.1.1 Mylan Company Information 11.1.2 Mylan Ketoconazole Product Offered 11.1.3 Mylan Ketoconazole Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Mylan Main Business Overview 11.1.5 Mylan Latest Developments 11.2 Almirall 11.2.1 Almirall Company Information 11.2.2 Almirall Ketoconazole Product Offered 11.2.3 Almirall Ketoconazole Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Almirall Main Business Overview 11.2.5 Almirall Latest Developments 11.3 j&j 11.3.1 j&j Company Information 11.3.2 j&j Ketoconazole Product Offered 11.3.3 j&j Ketoconazole Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 j&j Main Business Overview 11.3.5 j&j Latest Developments 11.4 Taro Pharmaceutical 11.4.1 Taro Pharmaceutical Company Information 11.4.2 Taro Pharmaceutical Ketoconazole Product Offered 11.4.3 Taro Pharmaceutical Ketoconazole Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Taro Pharmaceutical Main Business Overview 11.4.5 Taro Pharmaceutical Latest Developments 11.5 Teva Pharmaceutical 11.5.1 Teva Pharmaceutical Company Information 11.5.2 Teva Pharmaceutical Ketoconazole Product Offered 11.5.3 Teva Pharmaceutical Ketoconazole Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Teva Pharmaceutical Main Business Overview 11.5.5 Teva Pharmaceutical Latest Developments 11.6 SANDOZ 11.6.1 SANDOZ Company Information 11.6.2 SANDOZ Ketoconazole Product Offered 11.6.3 SANDOZ Ketoconazole Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 SANDOZ Main Business Overview 11.6.5 SANDOZ Latest Developments 11.7 Strides Pharma 11.7.1 Strides Pharma Company Information 11.7.2 Strides Pharma Ketoconazole Product Offered 11.7.3 Strides Pharma Ketoconazole Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Strides Pharma Main Business Overview 11.7.5 Strides Pharma Latest Developments 12 Research Findings and Conclusion